# Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults

> **NCT02350751** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 94 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** MEDI8852
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02350751
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 94 (ACTUAL)
- **Last updated:** 2015-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02350751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02350751, "Phase 1 Placebo-controlled,Dose-escalation Study to Evaluate the Safety and Pharmacokinetics of MEDI8852 in Adults". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02350751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*